Ann: FDA Grants Orphan Drug Designation for Revascor, page-222

First 222 Last

Share
Profile

Follow
vasilios

3,848 Posts.

360

25/02/24

10:18

Post #: 72581675
Share

Originally posted by yanzifeisheng: ↑

This stock is a confidence trick and akin to receiving an email from a Nigerian prince asking for your bank account details.

it’s pretty amazing that so many people follow it and own shares, judging by the participation in this forum

after 20 years and having raised close to $A2bn it loses tens of millions per year and doesn’t have a path to profitability yet expenses have been ～A$100m per year for many years

the Dream-HF phase 3 trial for congestive heart failure was the
company’s hope and it failed primary and secondary endpoints. Reported reduction in heart attacks and stroke were from a very truncated subset of the trial’s 500+ patient population, only about 20%… basically an insignificant Phase 1/2 trial population… but just enough for the company to say it seems to raise more money to fund more trials.

there are many red flags such as:
-the same lead researcher/doctor for heart trials for over 15 years
-the same institutions always taking the raising (particularly M&G in London
-the same Australian broker for 20 years that exclusively does the raisings despite the company dangling the promise of raising fees to much larger brokers in order to get research coverage
-a wide range of potential diseases despite a lack of evidence to pursue trials, so as to increase potential market size for the company and raise the probability-adjusted valuation
-a history of trial failure and torched capital by other stem cell companies that have long gone out of business or been subsumed by MSB

in addition the price chart is awful, below the 2004 IPO price now and looks to be in very clear terminal decline.

Expand

because of clowns like you on this forum, I decided to play the cryptocurrency market to keep me entertained and away from this forum.

it’s repetitive, it’s like a clowns copy and paste competition. I don’t mind reading the opposite side but be constructive and transparent.

MSB Price at posting: 29.0¢ Sentiment: Buy Disclosure: Held
14 Upvote

0 Great analysis

Reply

Top Stories

DXB

Dimerix begins recruiting young kidney disease patients in Mexico for Phase 3

GTR

GTI extends uranium mineralisation at Lo Hema through development drilling

CU6

Clarity progresses SECuRE trial with positive safety results

CHN

Chalice jumps on Putin nickel export ban threat – but then there's bad news

3 stocks with antimony news on Thursday